• Wondering whether CorVel at US$57.11 is starting to look like value or still has risk priced in? This article walks through what the current market price may be implying.
• The stock is up 1.3% over the past month but has fallen 13.1% year to date and declined 49.8% over the past year. These moves can change how you think about both upside potential and downside risk.
• Recent attention around CorVel has focused on its role within the US healthcare sector and how investors are reassessing companies that provide services across workers' compensation, auto and health claims. These discussions have helped frame the sharp 1-year share price decline and may influence how you think about what is already priced into the stock.
• CorVel currently has a valuation score of 3/6. The rest of this article will break that down using different valuation approaches while also pointing you to an additional way to think about what the stock could be worth.

Find out why CorVel's -49.8% return over the last year is lagging behind its peers.

Approach 1: CorVel Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model projects a company’s future cash flows and then discounts them back to today using a required return, giving an estimate of what the business could be worth right now.

For CorVel, the model uses a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month Free Cash Flow is about $109.7 million. Simply Wall St then extends analyst style forecasts, with estimated Free Cash Flow reaching about $245.3 million in 2035. The intervening years gradually step up from 2026 onward according to the supplied projections.

Adding up all these discounted cash flows produces an estimated intrinsic value of $95.59 per share. Compared with the current share price of $57.11, the DCF output suggests the stock is about 40.3% undervalued on these assumptions.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests CorVel is undervalued by 40.3%. Track this in your watchlist or portfolio, or discover 50 more high quality undervalued stocks.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for CorVel.

Approach 2: CorVel Price vs Earnings

For a profitable company like CorVel, the P/E ratio is a helpful way to relate what you pay for each share to the earnings the business is currently generating. In general, higher growth expectations and lower perceived risk can justify a higher P/E, while slower expected growth or higher risk usually support a lower, more conservative multiple.

CorVel trades on a P/E of 27.63x, compared with the broader Healthcare industry average of 22.39x. The peer group used here has an average P/E of 79.83x, which is very high and can be skewed by a few expensive stocks.

Simply Wall St also uses a "Fair Ratio" for the preferred multiple, which is the P/E you might expect after adjusting for factors like CorVel’s earnings profile, its industry, profit margins, market cap and key risks. This type of Fair Ratio can be more useful than a straight comparison with peers or the industry because it aims to align the P/E with the company’s own fundamentals rather than relying on what other stocks are trading at.

However, in this case the Fair Ratio is not available, so it is not possible to categorise the stock as overvalued or undervalued using this method.

Result: ABOUT RIGHT

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your CorVel Narrative

Earlier it was mentioned that there is an even better way to understand valuation, so this is where Narratives come in.

A Narrative is simply the story you believe about a company, turned into numbers like future revenue, earnings and profit margins, which then links through to a Fair Value that you can compare with the current share price.

On Simply Wall St, Narratives are an easy tool on the Community page, used by millions of investors. There you can see how different stories about CorVel translate into different Fair Values and where those sit versus the current price to help you decide whether to act or wait.

These Narratives update automatically when new information such as earnings, filings or news is added. This helps keep the story, forecast and Fair Value aligned with the latest data.

For example, one CorVel Narrative might assume a relatively conservative Fair Value close to the current US$57.11 share price, while another could point to a materially higher figure, showing how different views on the same company can lead to very different decisions.

Do you think there's more to the story for CorVel? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.